Gabriele Demetz
Overview
Explore the profile of Gabriele Demetz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
51
Followers
0
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Demetz G, Laux M, Scherhag A, Hoekstra T, Suttorp M, Dekker F, et al.
Thromb J
. 2014 Sep;
12:18.
PMID: 25228850
Background: Erythropoietin (Epo) has been shown to improve myocardial function in models of experimental myocardial infarction, but has also been associated with a rise in thromboembolic events. Thus, the aim...
2.
Sonne C, Bott-Flugel L, Hauck S, Hadamitzky M, Lesevic H, Demetz G, et al.
Pacing Clin Electrophysiol
. 2013 Oct;
37(3):312-20.
PMID: 24164640
Aims: There is little consensus on optimal atrioventricular (AV) and ventricular-to-ventricular (VV) intervals in cardiac resynchronization therapy (CRT). The aim of this study was to examine a novel combination of...
3.
Demetz G, Ott I
Int J Inflam
. 2012 Apr;
2012:860301.
PMID: 22518344
The intimate connection between coagulation and inflammation in the pathogenesis of vascular disease has moved more and more into focus of clinical research. This paper focuses on the essential components...
4.
Steppich B, Demetz G, Schulz S, von Wedel J, Pogatsa-Murray G, Braun S, et al.
Thromb Res
. 2010 Nov;
127(2):119-21.
PMID: 21095620
Introduction: In the prospective, randomised, double-blind, placebo-controlled Regenerate Vital Myocardium by Vigorous Activation of Bone Marrow Stem Cells (REVIVAL)-2 trial patients with acute myocardial infarction (AMI) and successful mechanical reperfusion...
5.
Steppich B, Braun S, Stein A, Demetz G, Groha P, Schomig A, et al.
Thromb J
. 2009 Jul;
7:11.
PMID: 19570241
Objectives And Background: Tissue factor (TF) contributes to thrombosis following plaque disruption in acute coronary syndromes (ACS). Aim of the study was to investigate the impact of plasma TF activity...